StockData
Vor Biopharma Inc. logo

Vor Biopharma Inc. (VOR) stock

VORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 5/30
$18.18−0.79 (-4.16%)

Close on Nov 17, 2026Market cap $1.12BP/E –Yield –

Vor Biopharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Vor Biopharma's price to book ratio was 3.9× on Jul 31, 2025, against 0.5× a year earlier. Over the last 4 years it ranged from 0.4× to 3.9×, with a median of 1.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jul 31, 20253.9×+2.9
2024Dec 31, 20241.0×+0.2
2023Dec 29, 20230.9×−0.7
2022Dec 30, 20221.6×−0.2
2021Dec 31, 20211.8×–

More Vor Biopharma figures

See a number that looks wrong?